CLASS II Drug recall · Reported 16 Apr 2014 · FDA Enforcement Report

Ranitidine Tablets USP, 150 mg recalled by Glenmark Generics Inc., U

Glenmark Generics Inc. USA is recalling Ranitidine Tablets USP, 150 mg, distributed nationwide in the US. The recall was initiated on 18 Mar 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 12AN118A, Exp 10/14
Quantity recalled2904 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1229-2014
FDA event ID
67776
Recalling firm
Glenmark Generics Inc. USA, Mahwah, NJ
Classification
Class II
Status
Terminated
Recall initiated
18 Mar 2014
FDA classified
9 Apr 2014
Reported
16 Apr 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

18 Mar 2014Recall initiated by company
9 Apr 2014Classified by FDA+22 days
16 Apr 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Ranitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: Shasun Pharmaceuticals Limited, Unit-II R.S. No 32 33 & 34, Shasun Road, Periyakalapet, Puducherry, - 605 014, India; Manufactured for: Glenmark Generics Inc, USA, Mahwah, NJ 07430, UPC 3 68462 24805 8, NDC 68462-248-05.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.

Which lots are affected?

Lot 12AN118A, Exp 10/14

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Glenmark Generics Inc. USA

All 6

Other Ranitidine recalls

All 55